Searched for
DEWAS PLANT
Auto ancillary stocks: Time for a re-rating as transformation nears the finish line? 6 stocks with upside potential of up to 34%- Will peace get a chance, and bulls make a comeback? 5 large-cap stocks with an upside potential of up to 26%
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analysts
- Specialty chemicals: Is China still the same threat, or is this a contrarian moment? 7 stocks to be brought back on the watchlistWhen it comes to the Indian speciality chemicals sector, China and its dumping matters. But there have been subtle but significant changes ...13 May, 2026, 12.49 PM IST
- Secular, cyclical or war-dependent: A ratio to tell you what kind of growth you are buying. 6 stocks with upside potential of up to 29%Some valuation ratios are used because they are easy. The PE ratio is one of them. It is simple, familiar, and convenient. Not only for the...10 May, 2026, 06.51 AM IST
- In war, anything can happen; in investing, only management matters. 6 stocks from different sectors with upside potential of up to 27%Net margin is a useful metric. It tells you how much profit remains after costs, interest, and tax are deducted from revenue. But it does n...26 Apr, 2026, 06.12 AM IST
- German ban on Ranbaxy's Dewas product expands to entire EUAdding to Ranbaxy's regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export to all member coun...04 Dec, 2014, 07.35 PM IST
- Germany bars antibiotic drug from Ranbaxy's central India plantRanbaxy Laboratories Ltd has been barred by from exporting the antibiotic cephalosporin to Germany from its plant in central India.03 Dec, 2014, 09.38 PM IST
- Ranbaxy Laboratories recalls 29,790 packs of anti-allergy drug in USRanbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to de...02 May, 2014, 08.08 PM IST
- Exports to Europe from Ranbaxy's two plants to remain suspendedExports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, European health regulator EMA sai...09 Apr, 2014, 04.47 PM IST
- Ranbaxy suspends shipments of active ingredients from Toansa, Dewas plantsRanbaxy Laboratories said Tuesday it was suspending shipments from two of its plants following US import bans on its products over safety c...26 Feb, 2014, 02.36 AM IST
- Daiichi to cooperate with USFDA to resolve Ranbaxy concernsDaiichi Sankyo will work with US authorities to resolve issue of a ban imposed by USFDA on import of drugs from Mohali plant of Ranbaxy.24 Sep, 2013, 04.06 PM IST
- Ranbaxy seeks to assuage shareholders' worries after USFDA banRanbaxy Laboratories today sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock.21 Sep, 2013, 09.19 AM IST
- PIL seeking cancellation of Ranbaxy licence filed in Supreme CourtA plea has been filed in the SC seeking cancellation of Ranbaxy's licence on the grounds that it fudged data and sold adulterated products ...06 Jun, 2013, 09.28 AM IST
- H&R Johnson investing Rs 400 crore on capacity expansionTiles maker H&R Johnson said it is in the process of investing Rs 400 crore for capacity expansion at its nine plants across the country.22 Mar, 2013, 04.12 PM IST
- We are open to calculated risks and swift decisions: Arun Sawhney, CEO & MD, Ranbaxy LaboratoriesRanbaxy Laboratories has met several obligations mandated by the US drug regulator, but it is still uncertain when it can resume exports fr...27 Apr, 2012, 01.28 AM IST
- Ranbaxy Shares up on news about settlement talks with US FDADaiichi Sankyo-owned Ranbaxy has been negotiating with the US Food and Drug Administration and the Department of Justice for a comprehensiv...02 Aug, 2011, 03.52 AM IST
- Ranbaxy sells Vietnam biz, to exit another in growth bidRanbaxy Laboratories, India’s largest pharma company, has sold its Vietnam business and is also looking to divest another, as part of a rat...02 Nov, 2009, 02.04 AM IST
- Ranbaxy asks US FDA to re-inspect Dewas facilityIndia’s largest drugmaker Ranbaxy has invited the US drug regulator to re-inspect its manufacturing plant at Dewas, raising hopes of an ear...11 Sep, 2009, 12.06 AM IST
- Ranbaxy units face FDA heat after inspectionsSources said that USFDA has given a ‘not approved’ rating to new products manufactured at the facility, although this could not be independ...02 Jul, 2008, 03.42 AM IST
Load More
